In a recent report, we demonstrated that changes in methylation of HSPB1, CCND2, TIG1, DPYS, and, MAL, had significant prognostic effects in multivariate Cox models where death from prostate cancer was the study endpoint [11]. The gene discussed is DPYS; the disease is Familial prostate cancer.